Bio-Reference Laboratories Stock Price, News & Analysis (NASDAQ:BRLI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Bio-Reference Laboratories (NASDAQ:BRLI)

Bio-Reference Laboratories logoBio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.

Receive BRLI News and Ratings via Email

Sign-up to receive the latest news and ratings for BRLI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical & Diagnostic Laboratories
Sub-IndustryHealth Care Services
SectorHealthcare
SymbolNASDAQ:BRLI
CUSIP09057G60
Phone+1-201-7912186

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$1.82
Net IncomeN/A
Net Margins4.67%
Return on Equity12.67%
Return on Assets8.38%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Bio-Reference Laboratories (NASDAQ:BRLI) Frequently Asked Questions

What is Bio-Reference Laboratories' stock symbol?

Bio-Reference Laboratories trades on the NASDAQ under the ticker symbol "BRLI."

How were Bio-Reference Laboratories' earnings last quarter?

Bio-Reference Laboratories Inc (NASDAQ:BRLI) posted its earnings results on Thursday, December, 18th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.63 by $0.03. The medical research company had revenue of $227.60 million for the quarter, compared to analysts' expectations of $228.81 million. Bio-Reference Laboratories had a net margin of 4.67% and a return on equity of 12.67%. The business's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.40 EPS. View Bio-Reference Laboratories' Earnings History.

Who are some of Bio-Reference Laboratories' key competitors?

How do I buy Bio-Reference Laboratories stock?

Shares of Bio-Reference Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Bio-Reference Laboratories?

Bio-Reference Laboratories' mailing address is 481 Edward H Ross Dr, ELMWOOD PARK, NJ 07407-3118, United States. The medical research company can be reached via phone at +1-201-7912186.


MarketBeat Community Rating for Bio-Reference Laboratories (BRLI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  120
MarketBeat's community ratings are surveys of what our community members think about Bio-Reference Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bio-Reference Laboratories (NASDAQ:BRLI) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Bio-Reference Laboratories (NASDAQ:BRLI) Earnings History and Estimates Chart

Earnings by Quarter for Bio-Reference Laboratories (NASDAQ:BRLI)

Bio-Reference Laboratories (NASDAQ BRLI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/8/2015Q215$0.46$0.38$227.33 million$224.00 millionViewListenView Earnings Details
3/5/2015Q115$0.36$0.24$216.40 million$209.00 millionViewListenView Earnings Details
12/18/2014Q414$0.63$0.66$228.81 million$227.60 millionViewListenView Earnings Details
8/27/2014Q314$0.53$0.55$210.44 million$222.10 millionViewListenView Earnings Details
6/5/2014Q214$0.32$0.37$0.20 million$201.30 millionViewListenView Earnings Details
3/4/2014Q114$0.14$0.11$175.52 million$181.30 millionViewListenView Earnings Details
12/19/2013Q4$0.40$0.40$188.96 million$192.20 millionViewListenView Earnings Details
8/29/2013Q3 2013$0.51$0.53$183.50 million$185.40 millionViewListenView Earnings Details
6/6/2013Q2 2013$0.41$0.41$176.04 million$176.50 millionViewListenView Earnings Details
2/28/2013Q1 2013$0.28$0.31$165.44 million$161.30 millionViewListenView Earnings Details
12/6/20120.46$0.46$175.46 millionViewListenView Earnings Details
8/30/2012Q312$0.43$0.45$0.17 million$0.17 millionViewN/AView Earnings Details
6/7/2012$0.32$0.33ViewN/AView Earnings Details
3/1/2012$0.21$0.26ViewN/AView Earnings Details
12/8/2011$0.35$0.37ViewN/AView Earnings Details
8/25/2011$0.34$0.36ViewN/AView Earnings Details
5/26/2011$0.24$0.26ViewN/AView Earnings Details
3/3/2011$0.17$0.28ViewN/AView Earnings Details
12/16/2010$0.30$0.31$124.19 million$126.60 millionViewN/AView Earnings Details
8/26/2010Q3 2010$0.28$0.29ViewN/AView Earnings Details
3/4/2010Q1 2010$0.12$0.14ViewN/AView Earnings Details
12/17/2009Q4 2009$0.22$0.26ViewN/AView Earnings Details
9/2/2009Q3 2009$0.19$0.23ViewN/AView Earnings Details
6/4/2009Q2 2009$0.14$0.17ViewN/AView Earnings Details
3/5/2009Q1 2009$0.09$0.10ViewN/AView Earnings Details
12/18/2008Q4 2008$0.18$0.19ViewN/AView Earnings Details
9/4/2008Q3 2008$0.16$0.17ViewN/AView Earnings Details
6/5/2008Q2 2008$0.14$0.12ViewN/AView Earnings Details
3/6/2008Q1 2008$0.07$0.08ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Bio-Reference Laboratories (NASDAQ:BRLI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Bio-Reference Laboratories (NASDAQ:BRLI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Bio-Reference Laboratories (NASDAQ BRLI) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Bio-Reference Laboratories (NASDAQ:BRLI)

Bio-Reference Laboratories (NASDAQ BRLI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2013Howard DubinettCOOSell20,000$29.40$588,000.00345,138View SEC Filing  
6/27/2013Sam SingerCFOSell4,000$28.95$115,800.00View SEC Filing  
6/26/2013Sam SingerCFOSell6,000$28.50$171,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Bio-Reference Laboratories (NASDAQ BRLI) News Headlines

Source:

SEC Filings

Bio-Reference Laboratories (NASDAQ:BRLI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bio-Reference Laboratories (NASDAQ:BRLI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bio-Reference Laboratories (NASDAQ BRLI) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.